Prevalence  ||| S:0 E:11 ||| NNP
of  ||| S:11 E:14 ||| IN
renal  ||| S:14 E:20 ||| JJ
replacement  ||| S:20 E:32 ||| NN
therapy  ||| S:32 E:40 ||| NN
in  ||| S:40 E:43 ||| IN
Veneto  ||| S:43 E:50 ||| NNP
for  ||| S:50 E:54 ||| IN
2008 ||| S:54 E:58 ||| CD
,  ||| S:58 E:60 ||| ,
2009  ||| S:60 E:65 ||| CD
and  ||| S:65 E:69 ||| CC
2010  ||| S:69 E:74 ||| CD
The  ||| S:74 E:78 ||| DT
aim  ||| S:78 E:82 ||| NN
of  ||| S:82 E:85 ||| IN
this  ||| S:85 E:90 ||| DT
section  ||| S:90 E:98 ||| NN
is  ||| S:98 E:101 ||| VBZ
to  ||| S:101 E:104 ||| TO
provide  ||| S:104 E:112 ||| VB
descriptive  ||| S:112 E:124 ||| JJ
data  ||| S:124 E:129 ||| NNS
for  ||| S:129 E:133 ||| IN
end-stage  ||| S:133 E:143 ||| JJ
renal  ||| S:143 E:149 ||| JJ
disease  ||| S:149 E:157 ||| NN
( ||| S:157 E:158 ||| -LRB-
ESRD ||| S:158 E:162 ||| NNP
)  ||| S:162 E:164 ||| -RRB-
in  ||| S:164 E:167 ||| IN
the  ||| S:167 E:171 ||| DT
Veneto  ||| S:171 E:178 ||| NNP
Region  ||| S:178 E:185 ||| NNP
( ||| S:185 E:186 ||| -LRB-
Italy ||| S:186 E:191 ||| NNP
) ||| S:191 E:192 ||| -RRB-
.  ||| S:192 E:194 ||| .
Data  ||| S:194 E:199 ||| NNP
were  ||| S:199 E:204 ||| VBD
obtained  ||| S:204 E:213 ||| VBN
from  ||| S:213 E:218 ||| IN
the  ||| S:218 E:222 ||| DT
Veneto  ||| S:222 E:229 ||| NNP
Dialysis  ||| S:229 E:238 ||| NNP
and  ||| S:238 E:242 ||| CC
Transplantation  ||| S:242 E:258 ||| NNP
Registry  ||| S:258 E:267 ||| NNP
( ||| S:267 E:268 ||| -LRB-
VDTR ||| S:268 E:272 ||| NNP
) ||| S:272 E:273 ||| -RRB-
.  ||| S:273 E:275 ||| .
Patients  ||| S:275 E:284 ||| NNS
were  ||| S:284 E:289 ||| VBD
considered  ||| S:289 E:300 ||| VBN
to  ||| S:300 E:303 ||| TO
be  ||| S:303 E:306 ||| VB
prevalent  ||| S:306 E:316 ||| JJ
renal  ||| S:316 E:322 ||| JJ
replacement  ||| S:322 E:334 ||| NN
therapy  ||| S:334 E:342 ||| NN
( ||| S:342 E:343 ||| -LRB-
RRT ||| S:343 E:346 ||| NNP
)  ||| S:346 E:348 ||| -RRB-
patients  ||| S:348 E:357 ||| NNS
if  ||| S:357 E:360 ||| IN
alive  ||| S:360 E:366 ||| JJ
on  ||| S:366 E:369 ||| IN
31  ||| S:369 E:372 ||| CD
December  ||| S:372 E:381 ||| NNP
of  ||| S:381 E:384 ||| IN
each  ||| S:384 E:389 ||| DT
year  ||| S:389 E:394 ||| NN
examined ||| S:394 E:402 ||| VBD
.  ||| S:402 E:404 ||| .
Prevalence  ||| S:404 E:415 ||| NNP
is  ||| S:415 E:418 ||| VBZ
expressed  ||| S:418 E:428 ||| VBN
per  ||| S:428 E:432 ||| IN
million  ||| S:432 E:440 ||| CD
population  ||| S:440 E:451 ||| NN
( ||| S:451 E:452 ||| -LRB-
pmp ||| S:452 E:455 ||| LS
) ||| S:455 E:456 ||| -RRB-
.  ||| S:456 E:458 ||| .
The  ||| S:458 E:462 ||| DT
trend  ||| S:462 E:468 ||| NN
for  ||| S:468 E:472 ||| IN
prevalence  ||| S:472 E:483 ||| NN
of  ||| S:483 E:486 ||| IN
each  ||| S:486 E:491 ||| DT
treatment  ||| S:491 E:501 ||| NN
in  ||| S:501 E:504 ||| IN
the  ||| S:504 E:508 ||| DT
period  ||| S:508 E:515 ||| NN
examined  ||| S:515 E:524 ||| NNS
was  ||| S:524 E:528 ||| VBD
estimated  ||| S:528 E:538 ||| VBN
by  ||| S:538 E:541 ||| IN
random  ||| S:541 E:548 ||| JJ
effects  ||| S:548 E:556 ||| NNS
longitudinal  ||| S:556 E:569 ||| VBP
logistic  ||| S:569 E:578 ||| JJ
regression ||| S:578 E:588 ||| NN
.  ||| S:588 E:590 ||| .
Prevalence  ||| S:590 E:601 ||| NNP
of  ||| S:601 E:604 ||| IN
RRT  ||| S:604 E:608 ||| NNP
in  ||| S:608 E:611 ||| IN
Veneto  ||| S:611 E:618 ||| NNP
in  ||| S:618 E:621 ||| IN
the  ||| S:621 E:625 ||| DT
years  ||| S:625 E:631 ||| NNS
2008 ||| S:631 E:635 ||| CD
,  ||| S:635 E:637 ||| ,
2009  ||| S:637 E:642 ||| CD
and  ||| S:642 E:646 ||| CC
2010  ||| S:646 E:651 ||| CD
was  ||| S:651 E:655 ||| VBD
888 ||| S:655 E:658 ||| CD
,  ||| S:658 E:660 ||| ,
923  ||| S:660 E:664 ||| CD
and  ||| S:664 E:668 ||| CC
950  ||| S:668 E:672 ||| CD
pmp ||| S:672 E:675 ||| NN
,  ||| S:675 E:677 ||| ,
respectively ||| S:677 E:689 ||| RB
.  ||| S:689 E:691 ||| .
The  ||| S:691 E:695 ||| DT
prevalence  ||| S:695 E:706 ||| NN
of  ||| S:706 E:709 ||| IN
RRT  ||| S:709 E:713 ||| NNP
patients  ||| S:713 E:722 ||| NNS
by  ||| S:722 E:725 ||| IN
treatment  ||| S:725 E:735 ||| NN
modality  ||| S:735 E:744 ||| NNS
showed  ||| S:744 E:751 ||| VBD
a  ||| S:751 E:753 ||| DT
slight  ||| S:753 E:760 ||| JJ
increase  ||| S:760 E:769 ||| NN
for  ||| S:769 E:773 ||| IN
hemodialysis ||| S:773 E:785 ||| NN
,  ||| S:785 E:787 ||| ,
notable  ||| S:787 E:795 ||| JJ
stability  ||| S:795 E:805 ||| NN
for  ||| S:805 E:809 ||| IN
peritoneal  ||| S:809 E:820 ||| JJ
dialysis  ||| S:820 E:829 ||| NN
and  ||| S:829 E:833 ||| CC
a  ||| S:833 E:835 ||| DT
more  ||| S:835 E:840 ||| RBR
pronounced  ||| S:840 E:851 ||| JJ
increase  ||| S:851 E:860 ||| NN
for  ||| S:860 E:864 ||| IN
transplantation ||| S:864 E:879 ||| NN
.  ||| S:879 E:881 ||| .
Every  ||| S:881 E:887 ||| DT
year ||| S:887 E:891 ||| NN
,  ||| S:891 E:893 ||| ,
about  ||| S:893 E:899 ||| IN
10 ||| S:899 E:901 ||| CD
%  ||| S:901 E:903 ||| NN
of  ||| S:903 E:906 ||| IN
peritoneal  ||| S:906 E:917 ||| JJ
dialysis  ||| S:917 E:926 ||| NN
patients  ||| S:926 E:935 ||| NNS
shifted  ||| S:935 E:943 ||| VBN
to  ||| S:943 E:946 ||| TO
hemodialysis ||| S:946 E:958 ||| VB
,  ||| S:958 E:960 ||| ,
and  ||| S:960 E:964 ||| CC
12 ||| S:964 E:966 ||| CD
%  ||| S:966 E:968 ||| NN
received  ||| S:968 E:977 ||| VBD
a  ||| S:977 E:979 ||| DT
transplant ||| S:979 E:989 ||| NN
.  ||| S:989 E:991 ||| .
The  ||| S:991 E:995 ||| DT
transition  ||| S:995 E:1006 ||| NN
probability  ||| S:1006 E:1018 ||| NN
from  ||| S:1018 E:1023 ||| IN
hemodialysis  ||| S:1023 E:1036 ||| VBG
to  ||| S:1036 E:1039 ||| TO
peritoneal  ||| S:1039 E:1050 ||| JJ
dialysis  ||| S:1050 E:1059 ||| NN
was  ||| S:1059 E:1063 ||| VBD
negligible ||| S:1063 E:1073 ||| JJ
,  ||| S:1073 E:1075 ||| ,
and  ||| S:1075 E:1079 ||| CC
less  ||| S:1079 E:1084 ||| JJR
than  ||| S:1084 E:1089 ||| IN
5 ||| S:1089 E:1090 ||| CD
%  ||| S:1090 E:1092 ||| NN
of  ||| S:1092 E:1095 ||| IN
hemodialysis  ||| S:1095 E:1108 ||| JJ
patients  ||| S:1108 E:1117 ||| NNS
received  ||| S:1117 E:1126 ||| VBD
a  ||| S:1126 E:1128 ||| DT
transplant ||| S:1128 E:1138 ||| NN
.  ||| S:1138 E:1140 ||| .
The  ||| S:1140 E:1144 ||| DT
probability  ||| S:1144 E:1156 ||| NN
of  ||| S:1156 E:1159 ||| IN
returning  ||| S:1159 E:1169 ||| VBG
to  ||| S:1169 E:1172 ||| TO
hemodialysis  ||| S:1172 E:1185 ||| VB
after  ||| S:1185 E:1191 ||| IN
having  ||| S:1191 E:1198 ||| VBG
received  ||| S:1198 E:1207 ||| VBN
a  ||| S:1207 E:1209 ||| DT
transplant  ||| S:1209 E:1220 ||| NN
was  ||| S:1220 E:1224 ||| VBD
less  ||| S:1224 E:1229 ||| JJR
than  ||| S:1229 E:1234 ||| IN
2 ||| S:1234 E:1235 ||| CD
%  ||| S:1235 E:1237 ||| NN
a  ||| S:1237 E:1239 ||| DT
year ||| S:1239 E:1243 ||| NN
.  ||| S:1243 E:1245 ||| .
Bicarbonate  ||| S:1245 E:1257 ||| NNP
hemodialysis  ||| S:1257 E:1270 ||| VBD
slowly  ||| S:1270 E:1277 ||| RB
increased  ||| S:1277 E:1287 ||| VBN
from  ||| S:1287 E:1292 ||| IN
1998  ||| S:1292 E:1297 ||| CD
to  ||| S:1297 E:1300 ||| TO
2010 ||| S:1300 E:1304 ||| CD
,  ||| S:1304 E:1306 ||| ,
both  ||| S:1306 E:1311 ||| DT
in  ||| S:1311 E:1314 ||| IN
percentage  ||| S:1314 E:1325 ||| NN
and  ||| S:1325 E:1329 ||| CC
in  ||| S:1329 E:1332 ||| IN
prevalence  ||| S:1332 E:1343 ||| NN
per  ||| S:1343 E:1347 ||| IN
million  ||| S:1347 E:1355 ||| CD
population ||| S:1355 E:1365 ||| NN
;  ||| S:1365 E:1367 ||| :
conversely ||| S:1367 E:1377 ||| CD
,  ||| S:1377 E:1379 ||| ,
hemodiafiltration  ||| S:1379 E:1397 ||| NNS
( ||| S:1397 E:1398 ||| -LRB-
HDF ||| S:1398 E:1401 ||| NNP
)  ||| S:1401 E:1403 ||| -RRB-
showed  ||| S:1403 E:1410 ||| VBD
a  ||| S:1410 E:1412 ||| DT
mild  ||| S:1412 E:1417 ||| JJ
but  ||| S:1417 E:1421 ||| CC
constant  ||| S:1421 E:1430 ||| JJ
decrease ||| S:1430 E:1438 ||| NN
.  ||| S:1438 E:1440 ||| .
Automated  ||| S:1440 E:1450 ||| JJ
peritoneal  ||| S:1450 E:1461 ||| JJ
dialysis  ||| S:1461 E:1470 ||| NN
( ||| S:1470 E:1471 ||| -LRB-
APD ||| S:1471 E:1474 ||| NNP
) ||| S:1474 E:1475 ||| -RRB-
,  ||| S:1475 E:1477 ||| ,
which  ||| S:1477 E:1483 ||| WDT
was  ||| S:1483 E:1487 ||| VBD
quantitatively  ||| S:1487 E:1502 ||| VBN
almost  ||| S:1502 E:1509 ||| RB
negligible  ||| S:1509 E:1520 ||| JJ
in  ||| S:1520 E:1523 ||| IN
1998 ||| S:1523 E:1527 ||| CD
,  ||| S:1527 E:1529 ||| ,
reached  ||| S:1529 E:1537 ||| VBD
the  ||| S:1537 E:1541 ||| DT
same  ||| S:1541 E:1546 ||| JJ
level  ||| S:1546 E:1552 ||| NN
as  ||| S:1552 E:1555 ||| IN
continuous  ||| S:1555 E:1566 ||| FW
ambulatory  ||| S:1566 E:1577 ||| FW
peritoneal  ||| S:1577 E:1588 ||| FW
dialysis  ||| S:1588 E:1597 ||| FW
( ||| S:1597 E:1598 ||| -LRB-
CAPD ||| S:1598 E:1602 ||| NNP
)  ||| S:1602 E:1604 ||| -RRB-
in  ||| S:1604 E:1607 ||| IN
2010 ||| S:1607 E:1611 ||| CD
.  ||| S:1611 E:1613 ||| .
The  ||| S:1613 E:1617 ||| DT
prevalence  ||| S:1617 E:1628 ||| NN
of  ||| S:1628 E:1631 ||| IN
patients  ||| S:1631 E:1640 ||| NNS
undergoing  ||| S:1640 E:1651 ||| VBP
living  ||| S:1651 E:1658 ||| VBG
donor  ||| S:1658 E:1664 ||| NN
transplants  ||| S:1664 E:1676 ||| NNS
almost  ||| S:1676 E:1683 ||| RB
doubled  ||| S:1683 E:1691 ||| VBN
in  ||| S:1691 E:1694 ||| IN
the  ||| S:1694 E:1698 ||| DT
period  ||| S:1698 E:1705 ||| NN
1998-2010 ||| S:1705 E:1714 ||| NN
.  ||| S:1714 E:1716 ||| .
The  ||| S:1716 E:1720 ||| DT
increase  ||| S:1720 E:1729 ||| NN
of  ||| S:1729 E:1732 ||| IN
prevalence  ||| S:1732 E:1743 ||| NN
over  ||| S:1743 E:1748 ||| IN
time  ||| S:1748 E:1753 ||| NN
was  ||| S:1753 E:1757 ||| VBD
not  ||| S:1757 E:1761 ||| RB
proportional  ||| S:1761 E:1774 ||| VBN
for  ||| S:1774 E:1778 ||| IN
the  ||| S:1778 E:1782 ||| DT
3  ||| S:1782 E:1784 ||| CD
modalities  ||| S:1784 E:1795 ||| NN
of  ||| S:1795 E:1798 ||| IN
RRT ||| S:1798 E:1801 ||| NNP
:  ||| S:1801 E:1803 ||| :
hemodialysis  ||| S:1803 E:1816 ||| JJ
prevalence  ||| S:1816 E:1827 ||| NN
grew  ||| S:1827 E:1832 ||| VBD
slowly ||| S:1832 E:1838 ||| RB
,  ||| S:1838 E:1840 ||| ,
peritoneal  ||| S:1840 E:1851 ||| JJ
dialysis  ||| S:1851 E:1860 ||| NN
prevalence  ||| S:1860 E:1871 ||| NNS
remained  ||| S:1871 E:1880 ||| VBD
stable ||| S:1880 E:1886 ||| JJ
,  ||| S:1886 E:1888 ||| ,
and  ||| S:1888 E:1892 ||| CC
renal  ||| S:1892 E:1898 ||| JJ
transplant  ||| S:1898 E:1909 ||| NN
prevalence  ||| S:1909 E:1920 ||| VBZ
quickly  ||| S:1920 E:1928 ||| RB
increased ||| S:1928 E:1937 ||| VBN
.  ||| S:1937 E:1939 ||| .
